Health - Google News: FDA Panel Sends Mixed Message on Pfizer Drug - MedPage Today

Health - Google News Google News

FDA Panel Sends Mixed Message on Pfizer Drug - MedPage Today May 24th 2012, 22:46 FDA Panel Sends Mixed Message on Pfizer Drug MedPage Today By Emily P. Walker, Washington Correspondent, MedPage Today WASHINGTON -- An FDA advisory panel considering an investigational drug to treat a rare nerve disorder agreed that a study of the drug, tafamidis meglumine (Vyndaqel), did not provide proof of ... FDA panel votes against Pfizer rare disease drugMSN Money Pfizer Says FDA Committee Find Data Support Effectiveness Of Tafamidis MeglumineNASDAQ FDA Panel: Data Could Support Approval Of Pfizer Drug TafamidisFox Business Wall Street Journal all 27 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: